Transforming Patient Identification for Rare Disease

Client Need: A pharmaceutical company specializing in rare diseases faced significant challenges in identifying and reaching patients who could benefit from their life-saving therapies. The patient data was fragmented across multiple systems, leading to delays and inefficiencies in patient identification. Moreover, the lack of access to real-time insights on patient demographics and treatment history hindered the company’s ability to develop personalized outreach strategies. This gap not only affected patient outcomes but also limited the company’s commercial success in connecting therapies with the right patients at the right time.

TrieDatum’s Solution: TrieDatum implemented a comprehensive data-driven solution designed to address the client’s challenges and optimize patient identification processes. The approach was anchored on three core pillars:

1. Data Integration and Centralization:

• A wizard-driven application was developed to simplify the process of onboarding protocol files.
• Automated metadata extraction and vectorization capabilities were integrated to enable the efficient organization and analysis of content.
• The system prepared protocols for GenAI processing, ensuring seamless analysis and summary generation.

2. Advanced Patient Segmentation:

• Leveraging advanced analytics, TrieDatum identified high-priority patient groups most likely to benefit from targeted therapies.
• The solution employed geographic and demographic targeting, allowing for precise identification of underserved regions and patient populations.
• Predictive models were utilized to forecast patient needs, ensuring proactive engagement.

3. Collaboration with Healthcare Providers:

• TrieDatum facilitated alignment with healthcare providers to ensure seamless data sharing and integration.
• The collaboration enabled improved outreach strategies and fostered trust and engagement with medical professionals.
• This partnership ensured that therapies were introduced to patients with minimal delay, fostering better healthcare outcomes.

Outcome: TrieDatum’s solution delivered transformative results for the client, driving measurable improvements in both patient outcomes and operational efficiency:

• Enhanced Patient Identification: The commercial team efficiently identified and prioritized patients most likely to benefit from their therapies, reducing the time spent on manual data analysis.
• Faster Access to Treatments: The company’s streamlined processes and targeted outreach enhanced therapy adoption rates, driving revenue growth and market penetration.
• Informed Decision-Making: Real-time analytics empowered the client to make data-driven decisions, adapt to market dynamics, and refine their strategies continually.

Conclusion: TrieDatum’s expertise in data integration, advanced analytics, and collaborative healthcare solutions enabled the client to overcome significant barriers in patient identification for rare diseases. By unifying data, enabling real-time insights, and fostering collaboration, TrieDatum transformed the client’s ability to connect with patients efficiently and effectively. This case underscores TrieDatum’s commitment to delivering impactful, patient-centric solutions that drive both clinical and commercial success.